Resistance and Aerobic Exercise With Nutritional Supplementation in Men and Women
NCT ID: NCT00812409
Last Updated: 2013-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
580 participants
INTERVENTIONAL
2007-04-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multidisciplinary Research Into the Effects of Resistance Exercise and Whey Protein Supplementation in Healthy Older Men
NCT03299972
Dietary Supplements and Exercise in Aging Adults
NCT00761553
Whey Protein Supplementation Associated With Resistance Training on Health Indicators in Trained Older Women
NCT03247192
Effect of Whey Protein Supplementation and Resistance Exercise on Muscle Parameters in Older Adults
NCT00635739
Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength
NCT01749189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Control group: non-protein supplement with resistance and aerobic exercise.
Non protein supplementation with exercise (control)
Non protein supplementation with resistance and aerobic exercise.
2
Low protein supplement with resistance and aerobic exercise.
Whey protein supplementation with exercise
Whey protein supplementation with resistance and aerobic exercise.
3
Moderate protein supplement with resistance and aerobic exercise.
Whey protein supplementation with exercise
Whey protein supplementation with resistance and aerobic exercise.
4
High protein supplement with resistance and aerobic exercise.
Whey protein supplementation with exercise
Whey protein supplementation with resistance and aerobic exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whey protein supplementation with exercise
Whey protein supplementation with resistance and aerobic exercise.
Non protein supplementation with exercise (control)
Non protein supplementation with resistance and aerobic exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body weight \<300 lbs (136 kg)
* body mass index between 28 kg/m2 and 35 kg/m2
* fasting glucose \<110 mg/dL
* blood pressure \<160/100 mm Hg
* plasma total cholesterol \<260 mg/dL
* LDL-cholesterol \<160 mg/dL
* triacylglycerol \<400 mg/dL
* not currently or previously following a weight loss diet or other special/non-balanced diet (in the past 6 months)
* \<1 hour/week of habitual aerobic exercise training and no resistance
* exercise training (in the past 6 months)
Exclusion Criteria
* body weight \>300 lbs (136 kg)
* body mass index between \<28 kg/m2 or \>35 kg/m2
* fasting glucose \>110 mg/dL
* blood pressure \>160/100 mm Hg
* plasma total cholesterol \>260 mg/dL
* LDL-cholesterol \>160 mg/dL
* triacylglycerol \>400 mg/dL
* currently or previously following a weight loss diet or other special/non- balanced diet (in the past 6 months)
35 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wayne Campbell
Wayne Campbell, Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wayne W Campbell, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Purdue University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue University
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wright CS, McMorrow AM, Weinheimer-Haus EM, Campbell WW. Whey Protein Supplementation and Higher Total Protein Intake Do Not Influence Bone Quantity in Overweight and Obese Adults Following a 36-Week Exercise and Diet Intervention. J Nutr. 2017 Feb;147(2):179-186. doi: 10.3945/jn.116.240473. Epub 2016 Dec 21.
Wright CS, Weinheimer-Haus EM, Fleet JC, Peacock M, Campbell WW. The Apparent Relation between Plasma 25-Hydroxyvitamin D and Insulin Resistance is Largely Attributable to Central Adiposity in Overweight and Obese Adults. J Nutr. 2015 Dec;145(12):2683-9. doi: 10.3945/jn.115.220541. Epub 2015 Oct 7.
Campbell WW, Kim JE, Amankwaah AF, Gordon SL, Weinheimer-Haus EM. Higher Total Protein Intake and Change in Total Protein Intake Affect Body Composition but Not Metabolic Syndrome Indexes in Middle-Aged Overweight and Obese Adults Who Perform Resistance and Aerobic Exercise for 36 Weeks. J Nutr. 2015 Sep;145(9):2076-83. doi: 10.3945/jn.115.213595. Epub 2015 Aug 5.
Weinheimer EM, Conley TB, Kobza VM, Sands LP, Lim E, Janle EM, Campbell WW. Whey protein supplementation does not affect exercise training-induced changes in body composition and indices of metabolic syndrome in middle-aged overweight and obese adults. J Nutr. 2012 Aug;142(8):1532-9. doi: 10.3945/jn.111.153619. Epub 2012 Jun 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07053552
Identifier Type: -
Identifier Source: secondary_id
0611004694
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.